Activation of the JAK/STAT3 pathway confers resistance to breast cancer and breast cancer stem cell lines. Inhibition of JAK/STAT3 led to inhibition of CPT-1b and abolished CSC self-renewal capabilities. The gene discussed is STAT3; the disease is breast cancer.